Literature DB >> 309948

Synthesis and analgesic-antiinflammatory activity of some 4- and 5-substituted heteroarylsalicylic acids.

H Jones, M W Fordice, R B Greenwald, J Hannah, A Jacobs, W V Ruyle, G L Walford, T Y Shen.   

Abstract

We have made a series of 4- and 5-aryl- and 4- and 5-heteroarylsalicylic acid derivatives with the objective of reducing gastric irritation and increasing potency. Here we describe a series of 4- and 5-heterocyclic salicylic acids and their antiinflammatory-analgesic potencies measured in comparison to aspirin. An improvement of the therapeutic index over aspirin of 100 was achieved; however, the heterocyclic salicylic acids lacked antipyretic activity. Some physicochemical parameters which may bear on the antiinflammatory activity of these compounds are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309948     DOI: 10.1021/jm00209a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents.

Authors:  Jianjun Chen; Zhao Wang; Chien-Ming Li; Yan Lu; Pavan K Vaddady; Bernd Meibohm; James T Dalton; Duane D Miller; Wei Li
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

2.  Analgesic activity of new pyrazine CH and NH acids and their hydrophobic and electron donating properties.

Authors:  R Kaliszan; B Pilarski; K Ośmiałowski; H Strzałkowska-Grad; E Hać
Journal:  Pharm Weekbl Sci       Date:  1985-08-23

3.  Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.

Authors:  Sanjeev Kumar; Daniel Jaller; Bhumika Patel; Judith M LaLonde; James B DuHadaway; William P Malachowski; George C Prendergast; Alexander J Muller
Journal:  J Med Chem       Date:  2008-07-30       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.